Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as doxorubicin and cyclophosphamide, work in different ways
to stop tumor cells from dividing so they stop growing or die. Tipifarnib may stop the growth
of tumor cells by blocking the enzymes necessary for their growth. Combining tipifarnib with
doxorubicin and cyclophosphamide may kill more tumor cells. Phase II trial to study the
effectiveness of combining tipifarnib with doxorubicin and cyclophosphamide in treating women
who have locally advanced breast cancer.